abstract |
Provided herein are compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)- l- ((tran)S-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2( 1H)-one, solid forms, isotopologues and metabolites thereof, and methods of their use for the treatment of a disease disorder, or condition. |